Opportunity, are you attempting to claim Aileron Therapeutics is some one horse company like BioCurex? Look at a press release back in 2007. You can bet that Roche would not lay out that kind of money on unproven technology with a company that pays penny stock promoters to hype their stock. If you notice, even after the latest patent filing, Taglich still leaves their rating at NEUTRAL.